Pfizer (PFE) Receivables - Other (2010 - 2023)
Pfizer (PFE) posted quarterly Receivables - Other of $57.0 million for Q2 2023, down 57.14% year-over-year from $133.0 million in Q2 2022, and down 79.04% quarter-over-quarter from $272.0 million in Q3 2022.
Pfizer (PFE) Receivables - Other (2010 - 2023) Analysis & Trends
Pfizer (PFE) has reported Receivables - Other for 5 consecutive years, with $57.0 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Receivables - Other fell 57.14% year-over-year to $57.0 million; the TTM figure through Apr 2023 stood at $57.0 million (down 57.14% YoY), while the FY2021 annual figure was $53.0 million, down 86.78% from the prior year.
- Receivables - Other declined to $57.0 million in Q2 2023 per PFE's latest filing, from $272.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $871.0 million in Q2 2021 and bottomed at $53.0 million in Q4 2021.
- Historically, Receivables - Other has averaged $302.2 million across 4 years, with a median of $234.5 million in 2021.
- Annual changes were most pronounced in 2021 — Receivables - Other sank 86.78% — and 2022, when it tumbled 37.33%.
- Pfizer's Receivables - Other stood at $401.0 million in 2020, then tumbled by 86.78% to $53.0 million in 2021, then jumped by 413.21% to $272.0 million in 2022, then slumped by 79.04% to $57.0 million in 2023.
- Business Quant data shows PFE's Receivables - Other at $57.0 million in Q2 2023, $272.0 million in Q3 2022, and $133.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 2, 2023 | 57.00 Mn |
| Apr 2, 2023 | 57.00 Mn |
| Jul 3, 2022 | 272.00 Mn |
| Jul 3, 2022 | 272.00 Mn |
| Apr 3, 2022 | 133.00 Mn |
| Apr 3, 2022 | 133.00 Mn |
| Dec 31, 2021 | 53.00 Mn |
| Dec 31, 2021 | 53.00 Mn |
| Oct 3, 2021 | 197.00 Mn |
| Oct 3, 2021 | 197.00 Mn |
| Jul 4, 2021 | 434.00 Mn |
| Jul 4, 2021 | 434.00 Mn |
| Apr 4, 2021 | 871.00 Mn |
| Apr 4, 2021 | 871.00 Mn |
| Dec 31, 2020 | 401.00 Mn |
| Dec 31, 2020 | 401.00 Mn |
| Dec 31, 2010 | 405.00 Mn |
| Dec 31, 2010 | 405.00 Mn |